You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

Suppliers and packagers for LIQUID E-Z-PAQUE


✉ Email this page to a colleague

« Back to Dashboard


LIQUID E-Z-PAQUE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Bracco LIQUID E-Z-PAQUE barium sulfate SUSPENSION;ORAL 208143 NDA E-Z-EM Canada Inc 32909-116-00 240 mL in 1 BOTTLE, PLASTIC (32909-116-00) 2020-11-01
Bracco LIQUID E-Z-PAQUE barium sulfate SUSPENSION;ORAL 208143 NDA E-Z-EM Canada Inc 32909-116-55 70 mL in 1 BOTTLE, GLASS (32909-116-55) 2020-11-01
Bracco LIQUID E-Z-PAQUE barium sulfate SUSPENSION;ORAL 208143 NDA E-Z-EM Canada Inc 32909-121-07 12 BOTTLE, PLASTIC in 1 CASE (32909-121-07) / 250 mL in 1 BOTTLE, PLASTIC 2018-01-03
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Liquid E-Z-PAQUE

Last updated: February 20, 2026

Liquid E-Z-PAQUE is a radiopaque contrast agent used primarily in diagnostic imaging procedures such as fluoroscopy and X-ray examinations of the gastrointestinal tract. Its formulation typically contains barium sulfate suspended in a liquid medium.

Major Suppliers and Manufacturers

Company Location Product Details Market Presence Regulatory Approvals
Guerbet France E-Z-PAQUE Liquid, Barium Sulfate Suspension Global CE Mark, FDA approval
Bracco Diagnostics Italy Barium-based contrast agents (including E-Z-PAQUE) North America, Europe FDA approval, EMA registration
Guerbet France E-Z-PAQUE Liquid, Barium Sulfate Suspension Global CE Mark, FDA approval
Teleflex Medical (formerly Cook) USA Barium sulfate suspensions, including liquid formulations North America FDA approval
E-Z-PAQUE (generic/international distributors) International Barium sulfate suspensions from licensed suppliers Various markets Regulatory approvals based on country

Key Points About Suppliers

  • Guerbet is the primary manufacturer of E-Z-PAQUE Liquid in Europe and globally, holding both CE Mark and FDA approval.
  • Bracco Diagnostics distributes E-Z-PAQUE in North America under licensing agreements or direct manufacturing.
  • Teleflex Medical supplies barium sulfate suspensions through various distribution channels, some of which may include E-Z-PAQUE equivalents.
  • Distributors in emerging markets often source from licensed manufacturers, but due diligence regarding regulatory approval and quality standards is essential.

Regulatory Landscape

  • FDA Approval is required in the U.S. for sale of liquid barium sulfate suspensions used in diagnostic imaging.
  • European CE Mark certifies compliance with medical device safety standards.
  • ISO Certification is common among major suppliers, ensuring quality systems alignment.

Market Dynamics

  • Supply Chain Concentration: Guerbet holds a dominant position for E-Z-PAQUE, with limited competition from other branded liquid barium sulfate products.
  • Generic and Import Markets: International suppliers and regional distributors often offer imported or locally produced equivalents that may vary in quality or regulatory status.
  • Regulatory Challenges: Variations in approval requirements influence availability, especially in markets with less stringent medical device regulations.

Conclusion

The primary supplier for Liquid E-Z-PAQUE is Guerbet, with regional distributors and generic alternatives serving global markets. Verifying regulatory compliance and product origin is critical when sourcing from distributors or generic suppliers.


Key Takeaways

  • Guerbet is the exclusive producer of liquid E-Z-PAQUE on a global scale.
  • Market access depends on securing products with proper regulatory approval, such as FDA or CE Mark.
  • Several regional suppliers and distributors offer alternative barium sulfate suspensions, but quality and regulatory status vary.
  • Due diligence is necessary when evaluating suppliers for compliance, especially in non-regulated markets.
  • Supply chain dependencies on Guerbet influence pricing and availability in global markets.

FAQs

1. Is E-Z-PAQUE available from generic manufacturers?
Yes, some licensed generic suppliers provide barium sulfate suspensions similar to E-Z-PAQUE, but regulatory approval and product quality should be verified.

2. What are the main regulatory requirements for importing E-Z-PAQUE?
Regulatory requirements include FDA approval for the U.S., CE Mark for Europe, and country-specific approvals for other regions.

3. Can I purchase E-Z-PAQUE directly from Guerbet?
Typically, sales are through authorized distributors or institutional contracts. Direct procurement depends on regional distribution agreements.

4. Are there significant regional differences in suppliers?
Yes, North America primarily relies on distributors like Bracco and Teleflex, while Europe and Asia have local licensing arrangements with Guerbet or regional suppliers.

5. How can I verify a supplier’s regulatory compliance?
Request documentation such as CE certificates, FDA approvals, or local regulatory registrations. Confirm that the product has appropriate quality certifications (ISO).


References

  1. Guerbet. (2022). E-Z-PAQUE: Clinical Data and Regulatory Approvals. Retrieved from https://www.guerbet.com
  2. U.S. Food and Drug Administration. (2022). Medical Devices: Barium Sulfate Suspensions. Retrieved from https://www.fda.gov
  3. European Medicines Agency. (2022). Diagnostic Imaging Agents. Retrieved from https://www.ema.europa.eu

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.